Iron(III) hydroxide polymaltose complex
Looking to order Iron(III) hydroxide polymaltose complex?
Browse our catalog for available pharmaceutical products and competitive pricing.
What is Iron(III) hydroxide polymaltose complex?
Iron(III) hydroxide polymaltose complex (IPC) is an effective oral iron supplement for treating and preventing iron deficiency anemia. Unlike some other iron preparations, IPC is a non-ionic, trivalent iron compound, where iron (Fe3+) is bound to a polymaltose carrier. This unique complex structure provides controlled iron release and a potentially lower incidence of gastrointestinal side effects compared to traditional ferrous salts.
This complex mimics physiological ferritin, the body's natural iron storage protein. The iron is surrounded by a carbohydrate (polymaltose) shell, preventing direct contact with the gastrointestinal mucosa. This encapsulation improves tolerability and absorption, making it a preferred choice for many patients, especially those sensitive to other iron supplements.
How Does it Work?
The mechanism of action of Iron(III) hydroxide polymaltose complex differs from ferrous iron salts. It remains stable in the stomach and releases iron in the small intestine via competitive ligand exchange. The ferric iron (Fe3+) in IPC is thought to be absorbed via paracellular pathways or specific receptor-mediated processes, not relying on active transport mechanisms saturated by traditional ferrous salts.
Once absorbed into enterocytes, ferric iron is reduced to ferrous iron (Fe2+) and transported into the bloodstream, binding to transferrin for delivery to bone marrow for erythropoiesis and to tissues for storage as ferritin. This controlled release minimizes free iron radicals, reducing gastrointestinal side effects and oxidative stress.
Medical Uses
The primary use of Iron(III) hydroxide polymaltose complex is treating and preventing iron deficiency anemia, a condition caused by insufficient iron for healthy red blood cell production. IPC is particularly beneficial for:
- Patients with intolerance to ferrous salts: Its better tolerability makes it an excellent alternative for those experiencing nausea, constipation, or diarrhea with conventional iron supplements.
- Pregnant women: IPC helps maintain adequate iron levels during pregnancy without exacerbating digestive issues.
- Children and adolescents: Suitable for pediatric use to meet high iron needs.
- Patients with chronic kidney disease: Can manage iron deficiency, often with erythropoiesis-stimulating agents.
- Post-surgical patients and those with chronic blood loss: Effective for ongoing iron depletion, providing sustained iron supplementation.
Dosage
Dosage of Iron(III) hydroxide polymaltose complex depends on deficiency severity, age, and medical conditions, and must follow professional recommendations. Adults with iron deficiency anemia typically take 100 mg to 200 mg of elemental iron daily, often in one or two doses. Lower doses are prescribed for prevention.
IPC is available in tablets, chewable tablets, syrups, and drops. It can generally be taken with or without food; some suggest taking it with food to minimize discomfort. Treatment usually continues for several months after iron levels normalize to replenish iron absorption stores (ferritin levels).
Side Effects
While generally well-tolerated, Iron(III) hydroxide polymaltose complex can cause side effects, though typically milder and less frequent than with ferrous preparations. Common side effects include:
- Darkening of stools: A harmless and expected effect.
- Mild gastrointestinal side effects: Nausea, abdominal discomfort, constipation, or diarrhea, usually transient and less severe.
- Temporary tooth discoloration: Rare with liquid forms; can be minimized by mixing with juice/water and brushing teeth.
Serious side effects are rare. Accidental overdose, especially in children, can be dangerous; keep all iron supplements out of reach of children.
Drug Interactions
A key advantage of Iron(III) hydroxide polymaltose complex is its lower risk of drug interactions compared to ferrous salts. IPC does not significantly interact with certain medications or food components that typically impair iron absorption:
- Antacids and Proton Pump Inhibitors (PPIs): IPC absorption is less affected by reduced stomach acid.
- Tetracyclines and Quinolones: Shows minimal interaction with these antibiotics.
- Calcium: High doses of calcium have less impact on IPC absorption.
- Food components: Phytates, oxalates, and tannins have less influence on IPC absorption, allowing more flexible dosing with meals.
Always inform your healthcare provider about all medications and supplements to ensure optimal treatment.
FAQ
Q: Is Iron(III) hydroxide polymaltose complex better than ferrous sulfate?
A: While both are effective, IPC often has better tolerability, leading to fewer gastrointestinal side effects and potentially better patient compliance, especially in sensitive individuals.
Q: How long does it take for Iron(III) hydroxide polymaltose complex to work?
A: Symptom improvement for iron deficiency anemia may be noticed within weeks. However, several months of consistent iron supplementation are typically needed to fully replenish iron stores.
Q: Can I take Iron(III) hydroxide polymaltose complex with food?
A: Yes, it can be taken with or without food. Taking it with food may further reduce the chance of mild stomach upset, as its iron absorption is less affected by food.
Q: What is the difference between ferric and ferrous iron?
A: Ferric iron (Fe3+) is trivalent, while ferrous iron (Fe2+) is bivalent. IPC contains ferric iron. The body needs to convert ferric iron to ferrous iron for utilization, which IPC's complex structure facilitates efficiently.
Products containing Iron(III) hydroxide polymaltose complex are available through trusted online pharmacies. You can browse Iron(III) hydroxide polymaltose complex-based medications at ShipperVIP or Medicenter.
Summary
Iron(III) hydroxide polymaltose complex is a modern and highly effective oral iron supplement for treating and preventing iron deficiency anemia. Its unique structure provides controlled release of ferric iron, leading to superior gastrointestinal tolerability and a lower risk of drug and food interactions compared to traditional ferrous salts. This makes it an excellent option for patients sensitive to other iron preparations, pregnant women, and children. Always consult a healthcare professional for appropriate diagnosis and dosage recommendations to ensure safe and effective iron supplementation.